Just - Evotec Biologics

company

About

Designing innovative technologies focused on accelerating global access to biotherapeutics.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$14M
Industries
Biotechnology
Founded date
Jan 1, 2014
Number Of Employee
101 - 250
Operating Status
Active

Just Evotec Biologics was founded in 2014 and acquired by Evotec in 2019. The company has an intense focus on the design of innovative and integrated technologies to accelerate the development of biotherapeutics and reduce their manufacturing cost. Core strengths include antibody discovery, molecular design, process and product design and manufacturing plant design.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$29M
Just - Evotec Biologics has raised a total of $29M in funding over 2 rounds. Their latest funding was raised on Jul 25, 2016 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 25, 2016 Series A $14M 3 Detail
Sep 21, 2015 Series A $15M 3 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Just - Evotec Biologics has made 1 investments. Their most recent investment was on Nov 2, 2021, when Upland raised $18M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 2, 2021 Upland
Series A $18M Blockchain

Investors

Number of Lead Investors
Number of Investors
3
Just - Evotec Biologics is funded by 3 investors. Merck and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Merck Series A
ARCH Venture Partners Series A
Lilly Asia Ventures Series A